Track AFT Pharmaceuticals Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

AFT Pharmaceuticals Limited AFT.NZ · Stock Open AFT Pharmaceuticals Limited in new tab

4.53 NZD
P/E
32.29
EPS
0.14
Yield
0.65%
Safety Score
48
P/B
4.30
ROE
13.66
Beta
0.52
Target Price
4.85 NZD
Loading chart...
Key Metrics
P/E32.29
EPS0.14
Book Value1.05
Price to Book4.30
Debt/Equity49.61
% Insiders77.635%
Growth
Revenue Growth0.15%
Earnings Growth-0.17%
Estimates
Forward P/E19.10
Forward EPS0.24
Target Mean Price4.85
Dividend
Dividend Yield0.65%
Annual dividends0.03 NZD
Ex-Div. DateJune 18, 2026
Payout12.81%

DCF valuation

Model fair value for AFT Pharmaceuticals Limited (AFT.NZ)
Result
Sign in to run the valuation for AFT.NZ.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
2 analysts · consensus None · mean target 4.85 NZD (low 4.65, high 5.05) · as of 15 Nov 2026
Low 4.65
Mean 4.85
High 5.05
Price 4.53
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

AFT Pharmaceuticals Limited Logo AFT Pharmaceuticals Limited Analysis (AFT.NZ)

New Zealand Health Care Official Website Stock

Is AFT Pharmaceuticals Limited a good investment? AFT Pharmaceuticals Limited (AFT.NZ) is currently trading at 4.53 NZD. Market analysts have a consensus price target of 4.85 NZD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 32.29. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, AFT Pharmaceuticals Limited pays a dividend yield of 0.65%. With a payout ratio of 13%, the dividend appears sustainable.

Investor FAQ

Does AFT Pharmaceuticals Limited pay a dividend?

Yes, it pays an annual dividend of 0.03 NZD (0.65% yield).

What asset class is AFT Pharmaceuticals Limited?

AFT Pharmaceuticals Limited is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers proprietary and in-licensed products, including patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, natural health, pain management, skin care, sleeping aids, supplements, and other products. It has a research and development collaboration with Hyloris Pharmaceuticals SA for the development of the Maxigesic IV product. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Exchange Ticker
ASX (Australia) AFP.AX
NZE (New Zealand) AFT.NZ
Trades
Dividend Yield
0.65%
Annual Dividends
0.03NZD
Next Ex. Div Date
June 18, 2026
Payout Ratio
12.81%
Dividend History paid per year (NZD)
Historical Dividends
Year Total Dividends
▸2027
0.02 NZD
July 5, 2027 (estimated) 0.0214
▸2026
0.03 NZD
July 3, 2026 0.0044
July 3, 2026 0.0250
▸2025
0.02 NZD
July 4, 2025 0.0180
▸2024
1.66 NZD
Dec. 5, 2024 0.1000
July 4, 2024 0.0160
June 23, 2024 1.5400
▸2023
1.51 NZD
Dec. 10, 2023 0.4000
July 4, 2023 0.0110
June 7, 2023 1.1000
▸2022
1.86 NZD
Nov. 23, 2022 0.4000
June 8, 2022 1.4600
▸2021
1.52 NZD
Dec. 1, 2021 0.4000
June 15, 2021 1.1200
▸2020
1.17 NZD
Nov. 25, 2020 0.3600
Sept. 2, 2020 0.8100
Upcoming Dividends
Name Payment Date Status Amount
AFT Pharmaceuticals Limited Jul 03, 2026 0.004412 NZD
AFT Pharmaceuticals Limited Jul 03, 2026 0.025 NZD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion